... of highly pathogenic bacteria – an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs. Most bacteria are harmless and do not cause infections. ...
... acids.
The fact that novel boron compounds will be unfamiliar to life has potential advantages for antibiotic drugs, since pathogens will be less able to develop resistance against them. "Also the ...
... 's structure, could lead to the development and commercial availability of a new class of antibiotic drugs.
"As a natural substance, it is what it is. If you want to design a better antibiotic, you ...
... . With thousands of known members of the Streptomyces family that could mean that AHFCAs could unlock hundreds of new antibiotics to replenish our dwindling arsenal of effective antibiotic drugs."
... , noted Collins.
The molecular alarm systems may also present new targets for antibiotic drugs. Historically, drugs have aimed their destructive powers at important cellular functions in the bacteria ...
... of the National Academies of Science. The findings could lead to new drugs that would disarm the increasingly antibiotic-resistant pathogen rather than attempting to kill it. Pseudomonas aeruginosa ...
... . Now, 60 years later, growing antibiotic resistance among pathogens has heavily depleted the arsenal of entailed effective antibiotic drugs.
Antibiotics function by attacking vital molecules in ...
... developed during the golden age of antibiotic drug discovery from 1930 to 1960, and then development ... completely different way of looking for a new antibiotic that would be active against the cell wall ...
... mechanisms at work in protein production, scientists have discovered why certain kinds of antibiotics are so effective. In doing so, they also have discovered how one protein protects against cell ...
... that differentiate bacteria from other organisms often occur in regions that are essential to ribosomal functioning, they will likely be targets for the development of new antibiotic drugs, she said.
... to do that in the small blood vessels, or capillaries, within our organs or extremities.
Antibiotic drugs have been the standard treatment for these conditions since the drugs were developed in the ...
... the face of environmental insults, such as action of a host immune system, or indeed of an antibiotic drug. Knowledge of how second messengers operate could therefore help combat bacterial infections ...
... agent that interacts with the LtaS binding site, as the basis for a new antibiotic drug.
They hope that in the future such a drug could be used to treat not just MRSA, but a whole host of infections ...
... developing resistance unlikely, LiPuma says.
"Given that this technology works differently from antibiotic drugs, it provides a potential alternative for treatment in antibiotic-resistant bacteria. ...
... second step also gives drug-makers a new target to consider, especially in the development of antibiotics. Drugs designed to interfere with the enzymes that make, find and repair the mistakes during ...
